During the past decade, Unidad de Investigación Clínica En Medicina SC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Unidad de Investigación Clínica En Medicina SC" #1 sponsor was "United Therapeutics" with 5 trials, followed by "Reata Pharmaceuticals, Inc." with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unidad de Investigación Clínica En Medicina SC" #1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Unidad de Investigación Clínica En Medicina SC" are "Pulmonary Arterial Hypertension" (6 trials), "Pulmonary Hypertension" (4 trials), "Cardiovascular Diseases" (2 trials), "Connective Tissue Diseases" (2 trials) and "Familial Primary Pulmonary Hypertension" (2 trials). Many other conditions were trialed in "Unidad de Investigación Clínica En Medicina SC" in a lesser frequency.

Most popular intervention types in "Unidad de Investigación Clínica En Medicina SC" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ralinepag" (2 trials), "Ambrisentan" (1 trials), "Apabetalone" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unidad de Investigación Clínica En Medicina SC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Unidad de Investigación Clínica En Medicina SC". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Unidad de Investigación Clínica En Medicina SC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Unidad de Investigación Clínica En Medicina SC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".